602 filings
Page 4 of 31
8-K
g5zu31dz2h7l5
24 Jun 21
Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance
6:05am
SD
uzzors3
1 Jun 21
Conflict minerals disclosure
8:00am
8-K
bjwmtb2jrjsavdb6
4 May 21
Results of Operations and Financial Condition
4:16pm
8-K
vcfzc tsovv64yy84644
30 Apr 21
Submission of Matters to a Vote of Security Holders
12:00am
8-K
s6n2d40lzc
13 Apr 21
Results of Operations and Financial Condition
4:46pm
25-NSE
285ijs
9 Apr 21
Exchange delisting
3:21pm
DEFA14A
ij1tm9uwu fbx38d7j5
10 Mar 21
Additional proxy soliciting materials
8:02am
8-K
qbnrwryr
8 Mar 21
Entry into a Material Definitive Agreement
4:11pm
424B5
45d3zkn
8 Mar 21
Prospectus supplement for primary offering
12:00am
FWP
uny5uaoxc6r2
4 Mar 21
Free writing prospectus
5:16pm
424B5
llqovs
4 Mar 21
Prospectus supplement for primary offering
8:41am
8-K
swo1j3pb40k65ez
2 Feb 21
Results of Operations and Financial Condition
4:11pm
DEFA14A
b9q9yufvibqc auu8
11 Jan 21
Additional proxy soliciting materials
5:21pm
8-K
4yackdvh93dc 0e
11 Jan 21
Regulation FD Disclosure
5:18pm
8-K
wimz0se76cfvxe
11 Jan 21
Results of Operations and Financial Condition
6:05am
DEFA14A
kwr mqrwk3kro
7 Jan 21
Additional proxy soliciting materials
4:32pm
8-K
fws 4263ddeuy1k69ks
7 Jan 21
PerkinElmer to Acquire Oxford Immunotec Global PLC
4:31pm